Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Date:11/10/2010

aeli pharmaceutical company focused primarily on acquisitions and development of late clinical-stage new formulations of existing drugs. Ondansetron is sold under the trade name Zofran©.

RedHill is the exclusive licensee of SCOLR's CDT platform for application to extended release tablet formulations of ondansetron.  Mr. Turner said, "We are encouraged that RedHill continues in its efforts to bring an extended release ondansetron tablet to market, and are pleased to continue our involvement in that process through these development services."In addition, in November SCOLR announced the award of approximately $250,000 in federal funds under the Therapeutic Discovery Project conducted by the Department of the Treasury and the Department of Health and Human Services.  The funds were awarded in connection with qualifying development expenses incurred during 2009 and earlier this year.

Included as part of the Patient Protection and Affordable Care Act of 2010, the Therapeutic Discovery Project program provided a tax credit to encourage investments in new therapies to prevent, diagnose, and treat acute and chronic diseases. Companies such as SCOLR that cannot currently use a tax credit were allowed to apply for a cash grant in lieu of a tax credit. SCOLR was awarded the grant funds primarily in connection with expenditures on its program for development of an extended release formulation of ibuprofen, as well as its programs for development of new ondansetron and peramivir formulations.

Third Quarter 2010 compared to Third Quarter 2009 Financial ResultsTotal revenues for the quarter ended September 30, 2010 were $124,000, a decrease of 53% compared to $262,000 for the same period in 2009. This decrease is due to a decrease in royalty income from our relationship with Perrigo.  Effective January 2010, commensurate with the amendment of our agreement with Perrigo, the royalty rate Perrigo pays us on sales of licensed products decr
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
2. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
3. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
4. SCOLR Pharma, Inc. Licenses Dietary Supplements
5. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
6. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
7. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
8. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
9. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
10. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
11. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  PTC Therapeutics, ... announce five recipients of its first-ever global awards ... Vision and Empowerment), designed to aid nonprofit organizations ... dystrophy (DMD) community. The announcement is made as ... World Duchenne Awareness Day on Monday, September 7, ...
(Date:9/4/2015)... , September 4, 2015 ... ), a clinical-stage pharmaceutical company focused on the development ... Company will participate in the upcoming Rodman & Renshaw ... September 8-10, 2015 in New York City ... Oramed, will present a corporate overview on September 9, ...
(Date:9/4/2015)... , September 4, 2015 Future ... Allergic Rhinitis drugs - new ... Where is the market for allergic rhinitis drugs ... Visiongain ,s new report shows you potential revenues ... prospects. Our 326 page report provides 273 ...
Breaking Medicine Technology:PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7
... Globus Medical, Inc., the largest,privately held spinal ... in motion preservation technology, today announced the completion ... study. The,SECURE(R)-C device is designed to mimic the ... pain and restore function as an alternative to ...
... Siemens Healthcare and,Laboratory Corporation of America(R) Holdings ... non-exclusive agreement to discuss future,possibilities to co-develop ... of,companion diagnostics, metabolic syndrome, oncology and diabetes. ... developing new tests that,could make the biggest ...
Cached Medicine Technology:Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 3Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 4
(Date:9/4/2015)... ... 04, 2015 , ... San Francisco cosmetic dentist , ... is a newer method for creating restorations through innovative imaging equipment and on-site ... need for multiple appointments, CEREC produces restorations with total precision for a natural ...
(Date:9/4/2015)... ... 04, 2015 , ... Bio-Logic Aqua® Research, a fresh water ... only mission and research focus: Water Life Science®. In the current warming and ... is becoming dangerously accelerated. As a result of the global fresh water, water ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... its first neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. ... area and feature 30 cottage or “pocket” homes. In this community, adults will ...
(Date:9/4/2015)... ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... involving the Pope’s upcoming trip to the United States. , Yisrayl lays out what he ... the Vatican and society is. Yisrayl also provides the meaning of his own name and ...
(Date:9/3/2015)... ... September 04, 2015 , ... AlignLife of Wauwatosa is excited to ... so many children and adults who don't have the ability to buy a jacket ... holding our annual Coat Drive to help those in need." , This is AlignLife's ...
Breaking Medicine News(10 mins):Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:AlignLife is Helping to Keep the Community Warm This Winter 2
... Case Western Reserve University School of Medicine has received ... Health to determine if painful bladder syndrome may be ... than in the bladder itself. Principal ... of neurology at the Case Western Reserve University School ...
... at The University of Nottingham are hoping to find out ... of osteoarthritis a condition which leads to pain, stiffness, ... the UK suffer from osteoarthritis in the knee. Now ... across Nottingham are to take part in a study led ...
... Va.SNM,s Clinical Trials Network today announced that several ... have registered their manufacturing sites with the network. ... to address the need for streamlined drug discovery ... clinical trials. According to Michael M. Graham, ...
... , FORT WORTH, Texas and AUSTIN, Texas, ... to announce a partnership with seven-time Tour de France winner Lance Armstrong ... Lance Armstrong will compete for Team RadioShack as a cyclist, runner and ... , , Lance Armstrong returned to the ...
... shows how ,plastic, these cells can be, experts say , ... named "Tiny," but what it represents in the world of ... the birth of Tiny (and Tiny,s brethren) marks a milestone ... pluripotent stem cells (iPS) derived not from embryonic cells, but ...
... , , American ... , ROSEMONT, Ill., July 23 The ... Registry (AJRR), a nonprofit organization dedicated to collecting and reporting on hip ... patient safety best practice. , , ...
Cached Medicine News:Health News:Case Western Reserve University receives $3.7M NIH grant to study autonomic nervous system link to painful bladder syndrome 2Health News:Detecting early signs of osteoarthritis 2Health News:SNM's Clinical Trials Network expands European membership of PET biomarker manufacturers 2Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 2Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 3Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 4Health News:Scientists Use Non-Embryonic Stem Cells to Create Healthy Mice 2Health News:Scientists Use Non-Embryonic Stem Cells to Create Healthy Mice 3Health News:American Joint Replacement Registry Announced 2
... Advantage delivers higher magnification for advanced surgical ... image, even at the highest magnification. 3.5x, ... and precise color rendition is ideal for ... anti-reflective coating produce a superior image. The ...
... higher magnification for advanced surgical procedures. Prismatic ... at the highest magnification. 3.5x, 4.5x and ... color rendition is ideal for surgical applications. ... produce a superior image. The compact abd ...
... up of doublet objective and high power ... and 3.0x. The true benefit of this ... maintaining focal clarity is made possible due ... ultra lightweight aluminum bar and individual interpupillary ...
... Left. 23 gauge thin wall ... Angled 20 degree shaft 10 mm ... set 0.5 mm behind aspiration tip. ... 46 cm (18.1 inches) of silicone ...
Medicine Products: